- Joined
- Nov 7, 2021
- Messages
- 149
Thanks for your input. Have you used it yourself?I don't hold a strong opinion on SGLT2 inhibitors, to me practically, they fall on a continuum of agents to manage (e.g., rhGH-induced) hyperglycemia that runs from Biguanides/BBR < SGLT-2 inhibitors < incretins < IGF-I & its analogues < insulin, that as you move along the continuum, you move from simple GDAs towards agents that in the middle augment insulin sensitivity on towards those that increase IGF-I bioavailability.
You'll notice some agents like sulfonylureas are absent. That's because I don't feel that there is a place for them.
With your knowledge in them, how applicable do you feel they are for someone trying to grow? Is there an effective way to negate the negatives?